ALLISON HITCHNER: Open Payments
NPI 1588909949 · MANAHAWKIN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$10,545 in 67 payments from 15 companies in 2025. Trend: 2023 $248 · 2024 $441 · 2025 $10,545
Speaker / faculty: $5,824Consulting: $2,473Food & beverage: $1,193Travel & lodging: $1,055
| Company | Payments | Amount |
|---|---|---|
| Biogen, Inc. | 26 | $9,760 |
| MAYNE PHARMA COMMERCIAL LLC | 7 | $181 |
| Astellas Pharma US Inc | 6 | $107 |
| Exeltis, USA Inc. | 4 | $81 |
| Amgen Inc. | 3 | $55 |
| Sage Therapeutics, LLC | 3 | $54 |
| Sumitomo Pharma America, Inc. | 3 | $53 |
| Evofem Biosciences, Inc. | 4 | $53 |
| MILLICENT US INC | 2 | $38 |
| Pacira Pharmaceuticals Incorporated | 2 | $38 |
Products named: ZURZUVAE, Veozah, BIJUVA, SLYND, EVENITY, MYFEMBREE, Phexxi, Exparel.
Industry payments across NJ — which companies pay providers there.
